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Objective: To analyze expression of keystone markers of apoptosis
and the proapoptotic signaling pathway “unfolded protein response”
(UPR) in rupture-prone plaques of the human carotid artery.
Methods: Plaque specimens were obtained during endarterectomy
for high-grade carotid stenosis, and were formalin-ﬁxed. Ten specimens
were identiﬁed that exhibited criteria of advanced rupture-prone atheroscle-
rotic plaques, and histological and immunohistological analysis of markers of
apoptosis (cleaved Caspase-3, TUNEL) and UPR (KDEL, ATF3, CHOP,
CHAC-1) was performed. In addition, co-localization of apoptosis and
UPR-activation was assessed by double-immunohistochemistry.
Results: The mean size of the necrotic core was 44 6 7% and the
mean minimum/representative thicknesses of the ﬁbrous cap were 129 6
39 mm/280 6 60 mm, respectively. Each specimen fulﬁlled at least two
of the criteria for rupture-prone plaques. Semi-quantitative analysis of
immunohistochemistry showed a signiﬁcant increase in cleaved Caspase-3-
positive (1923 6 93 cells/mm2) and TUNEL-positive cells (1387 6 66
cells/mm2) when compared with control tissue. Furthermore, expression
of UPR-markers KDEL, AFT3 and CHOP was signiﬁcantly increased
(1175 6 40 cells/mm2, 1971 6 69 cells/mm2 and 2173 6 120 cells/
mm2, respectively). Co-localization of UPR-activation with apoptosis was
conﬁrmed by double-immunohistochemistry, and lesional macrophages
were identiﬁed as the primary cell-type involved.
Conclusion: For the ﬁrst time, activation of the proapoptotic
signaling pathway UPR has been identiﬁed in advanced rupture-prone pla-
ques of the human carotid artery. This provides additional evidence for add-
ing UPR to the potential targets for controlling plaque apoptosis and
thereby preventing plaque progression/rupture.
Temporary Aneurysm Sac Perfusion as an Adjunct for Prevention of
Spinal Cord Ischemia After Branched Endovascular Repair of
Thoracoabdominal Aneurysms
Kasprzak P.M., Gallis K., Cucuruz B., Pﬁster K., Janotta M., Kopp R. Eur J
Vasc Endovasc Surg 2014;48:260-7.
Objective: To report experience with the concept of temporary aneu-
rysm sac perfusion (TASP) and second stage side branch completion to pre-
vent severe spinal cord ischemia (SCI) after branched endovascular aortic
repair (bEVAR) for thoracoabdominal aortic aneurysm (TAAA).
Methods: Patients were treated for TAAA with bEVAR between
January 2009 and September 2012. TASP was performed by non-comple-
tion of side branches to one of the reno-visceral arteries, distal aortic or iliac
extensions with secondary side branch completion. Primary endpoints of the
study were overall technical success, side branch patency, perioperative mor-
tality, and the rate of severe SCI.
Results: Eighty-three patients were treated for TAAA with branched
aortic stent grafts with (n = 40) or without (n = 43) TASP. Overall technical
success, including aneurysm exclusion, absence of persistent type I or III
endoleak, TASP side branch patency, and secondary side branch completion
was 35/40 (88%). Secondary TASP side branch completion was performed
after a median of 48 days (range 1 e370 days). The rate of early re-interven-
tions for reno-visceral side branch complications was 8/283 (3%) and 6/83
(7%) for perioperative mortality, with three patients in both groups. Severe
SCI or paraplegia was observed in 11/83 (13%) of the patients and reduced
in the TASP group (2/40) compared with the non-TASP group (9/43; p =
.03), especially in Crawford I eIII aneurysms (1/29 vs. 7/24; p = .01).
However, one TASP patient died 4 months after bEVAR during the
TASP interval from suspected aorto-bronchial ﬁstula.
Conclusion: The concept of TASP after bEVAR for TAAA is feasible
and seems to reduce the risk of SCI. Early side TASP branch completion
within 4 weeks is recommended to reduce the risk of rupture, although,according to the individual clinical presentation, a longer TASP interval
might improve neurological rehabilitation from SCI.
Endovascular Repair of Acute Uncomplicated Aortic Type B
Dissection Promotes Aortic Remodelling: 1 Year Results of the
ADSORB Trial
Brunkwall J., Kasprzak P., Verhoeven E., Heijmen R., Taylor P., the
ADSORB Trialists, Alric P., Canaud L., Janotta M., Raithel D.,
Malina M., Resch Ti., Eckstein H.-H., Ockert S., Larzon T., Carlsson F.,
Schumacher H., Classen S., Schaub P., Lammer J., Lönn L.,
Clough R.E., Rampoldi V., Trimarchi S., Fabiani J.-N., Böckler D.,
Kotelis D., Böckler D., Kotelis D., von Tenng-Kobligk H.,
Mangialardi N., Ronchey S., Dialetto G., Matoussevitch V. Eur J Vasc
Endovasc Surg 2014;48:287-93.
Objectives: Uncomplicated acute type B aortic dissection (AD)
treated conservatively has a 10% 30-day mortality and up to 25% need inter-
vention within 4 years. In complicated AD, stent grafts have been encour-
aging. The aim of the present prospective randomised trial was to
compare best medical treatment (BMT) with BMT and Gore TAG stent
graft in patients with uncomplicated AD. The primary endpoint was a com-
bination of incomplete/no false lumen thrombosis, aortic dilatation, or
aortic rupture at 1 year.
Methods: The AD history had to be less than 14 days, and exclusion
criteria were rupture, impending rupture, malperfusion. Of the 61 patients
randomised, 80% were DeBakey type IIIB.
Results: Thirty-one patients were randomised to the BMT group and
30 to the BMT+TAG group. Mean age was 63 years for both groups. The
left subclavian artery was completely covered in 47% and in part in 17% of
the cases. During the ﬁrst 30 days, no deaths occurred in either group,
but there were three crossovers from the BMT to the BMT+TAG group,
all due to progression of disease within 1 week. There were two withdrawals
from the BMT+TAG group. At the 1-year follow up there had been another
two failures in the BMT group: one malperfusion and one aneurysm forma-
tion (p = .056 for all). One death occurred in the BMT+TAG group. For
the overall endpoint BMT+TAG was signiﬁcantly different from BMT
only (p < .001). Incomplete false lumen thrombosis, was found in 13
(43%) of the TAG+BMT group and 30 (97%) of the BMT group (p <
.001). The false lumen reduced in size in the BMT+TAG group (p <
.001) whereas in the BMT group it increased. The true lumen increased
in the BMT+TAG (p < .001) whereas in the BMT group it remained un-
changed. The overall transverse diameter was the same at the beginning
and after 1 year in the BMT group (42.1 mm), but in the BMT+TAG it
decreased (38.8 mm; p = .062).
Conclusions: Uncomplicated AD can be safely treated with the Gore
TAG device. Remodelling with thrombosis of the false lumen and reduction
of its diameter is induced by the stent graft, but long term results are
needed.
In Situ Reconstruction in Native and Prosthetic Aortic Infections
Using Cryopreserved Arterial Allografts
Touma J., Cochennec F., Parisot J., Fialaire Legendre A., Becquemin J.-P.,
Desgranges P. Eur J Vasc Endovasc Surg 2014;48:294-301.
Objectives: To evaluate overall survival and complications of cryopre-
served arterial allografts in aortic graft infections and infected aortic
aneurysms.
Results: During the study period, 54 patients (45 [83%] men, mean
age 66.26 10.2 years) underwent aortic reconstruction using cryopreserved
allografts. Indications were native aortic infection in 17 patients and pros-
thetic graft infection in 37 patients, including seven aortoenteric ﬁstulae.
Twelve aortic reconstructions (22%) were performed as emergency proce-
dures. The median duration of follow-up was 12.1 months (range
0.4e83.6). The 30-day mortality rate was 28%. The overall mortality rate807
